Literature DB >> 8961380

Mechanisms of oxyradical production in substance P stimulated rheumatoid synovial cells.

T Tanabe1, H Otani, K Mishima, R Ogawa, C Inagaki.   

Abstract

We examined the intracellular mechanisms of substance P induced oxyradical production in rheumatoid synovial cells by the luminol-dependent chemiluminescence method. After stimulation with substance P (30 microM), single synovial A (macrophage-like) or B (fibroblast-like) cells released oxyradicals such as superoxide anions (O2-) and/or hypochlorous anions (OCl-) under a microscope equipped with an ultrasensitive photonic image intensifier. The substance P induced oxyradical production was blocked by a tachykinin NK1 (NK1) receptor antagonist, GR82334, GTP-binding protein (G-protein) inactivators, GDP beta S and islet-activating protein (IAP), and a phospholipase C (PLC) inhibitor, U-73122. Substance P (30 microM) also induced a transient increase in the intracellular Ca2+ concentration ([Ca2+]i) in both synovial A and B cells as measured by a Ca2+ indicator, fura 2, BAPTA-AM and an inositol-1,4-5-triphosphate (IP3) receptor antagonist, heparin, inhibited the substance P induced increase in [Ca2+]i, but they had no effects on oxyradical production. In contrast to the effects of BAPTA-AM and heparin, protein kinase C (PKC) inhibitors, H-7 and calphostin C, completely inhibited substance P induced oxyradical production without any significant effects on [Ca2+]i increase. These findings suggest that the NK1 receptor/PLC-linked diacylglycerol (DAG) formation with the resulting activation of PKC is the main signal transduction pathway for substance P stimulated oxyradical production in synovial cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8961380     DOI: 10.1007/bf01419729

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  28 in total

Review 1.  Substance P, cytokines, and arthritis.

Authors:  E S Kimball
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

2.  Phagocytic activation of a luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages.

Authors:  R C Allen; L D Loose
Journal:  Biochem Biophys Res Commun       Date:  1976-03-08       Impact factor: 3.575

3.  Expression of the collagenolytic and Ras-induced cysteine proteinase cathepsin L and proliferation-associated oncogenes in synovial cells of MRL/I mice and patients with rheumatoid arthritis.

Authors:  A Trabandt; W K Aicher; R E Gay; V P Sukhatme; M Nilson-Hamilton; R T Hamilton; J R McGhee; H G Fassbender; S Gay
Journal:  Matrix       Date:  1990-12

4.  Immunoreactive tachykinins, calcitonin gene-related peptide and neuropeptide Y in human synovial fluid from inflamed knee joints.

Authors:  J Larsson; A Ekblom; K Henriksson; T Lundeberg; E Theodorsson
Journal:  Neurosci Lett       Date:  1989-05-22       Impact factor: 3.046

Review 5.  Protein kinase C and the activation of the human neutrophil NADPH-oxidase.

Authors:  A I Tauber
Journal:  Blood       Date:  1987-03       Impact factor: 22.113

Review 6.  Pannus and pannocytes. Alternative models of joint destruction in rheumatoid arthritis.

Authors:  N J Zvaifler; G S Firestein
Journal:  Arthritis Rheum       Date:  1994-06

7.  The activation of calcium and calcium-activated potassium channels in mammalian colonic smooth muscle by substance P.

Authors:  E A Mayer; D D Loo; W J Snape; G Sachs
Journal:  J Physiol       Date:  1990-01       Impact factor: 5.182

8.  Tyrosine phosphorylation and oxygen consumption induced by G proteins in neutrophils.

Authors:  S Grinstein; W Furuya
Journal:  Am J Physiol       Date:  1991-05

9.  Substance P levels in the synovium and synovial fluid from patients with rheumatoid arthritis and osteoarthritis.

Authors:  C J Menkes; M Renoux; S Laoussadi; A Mauborgne; J Bruxelle; F Cesselin
Journal:  J Rheumatol       Date:  1993-04       Impact factor: 4.666

10.  Transforming growth factor-beta production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritic rats. Studies on secretion by synovial fibroblast-like cells and immunohistologic localization.

Authors:  R Lafyatis; N L Thompson; E F Remmers; K C Flanders; N S Roche; S J Kim; J P Case; M B Sporn; A B Roberts; R L Wilder
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

View more
  6 in total

Review 1.  Recent aspects of gonadal hormone and neurotransmitter interactions with synovial and immune cells: implications in rheumatoid arthritis.

Authors:  M Cutolo; R H Straub
Journal:  Ann Rheum Dis       Date:  2000-09       Impact factor: 19.103

2.  Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice.

Authors:  R A Tripp; D Moore; J Winter; L J Anderson
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Inhibition by heparin of protein kinase C activation and hydroxyl radical generation in puromycin aminonucleoside treated isolated rat hepatocytes.

Authors:  Kazumasa Aoyagi; Yutaka Kuzure; Siranoush Shahrzad; Aki Hirayama; Sohji Nagase; Atsushi Ueda
Journal:  Mol Cell Biochem       Date:  2003-02       Impact factor: 3.396

4.  Basic fibroblast growth factor accelerates matrix degradation via a neuro-endocrine pathway in human adult articular chondrocytes.

Authors:  Hee-Jeong Im; Xin Li; Prasuna Muddasani; Gun-Hee Kim; Francesca Davis; Jayanthi Rangan; Christopher B Forsyth; Michael Ellman; Eugene J M A Thonar
Journal:  J Cell Physiol       Date:  2008-05       Impact factor: 6.384

Review 5.  The role of peripheral nerve fibers and their neurotransmitters in cartilage and bone physiology and pathophysiology.

Authors:  Susanne G Grässel
Journal:  Arthritis Res Ther       Date:  2014       Impact factor: 5.156

Review 6.  Peripheral Nerve Fibers and Their Neurotransmitters in Osteoarthritis Pathology.

Authors:  Susanne Grässel; Dominique Muschter
Journal:  Int J Mol Sci       Date:  2017-04-28       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.